These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35443478)

  • 21. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
    Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
    Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
    Nishikawa M; Miyake H; Fujisawa M
    Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.
    Yin G; Man C; Liao S; Qiu H
    Mediators Inflamm; 2020; 2020():5719751. PubMed ID: 33376452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
    Rief P; Pichler M; Raggam R; Hafner F; Gerger A; Eller P; Brodmann M; Gary T
    Medicine (Baltimore); 2016 Jun; 95(24):e3843. PubMed ID: 27310963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients.
    Izhari MA
    Infect Drug Resist; 2024; 17():1653-1667. PubMed ID: 38707987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.
    Khalid A; Ali Jaffar M; Khan T; Abbas Lail R; Ali S; Aktas G; Waris A; Javaid A; Ijaz N; Muhammad N
    Hematology; 2021 Dec; 26(1):529-542. PubMed ID: 34334100
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic and prognostic value of the AST/ALT ratio in patients with sepsis and septic shock.
    Schupp T; Weidner K; Rusnak J; Jawhar S; Forner J; Dulatahu F; Brück LM; Hoffmann U; Bertsch T; Weiß C; Akin I; Behnes M
    Scand J Gastroenterol; 2023 Apr; 58(4):392-402. PubMed ID: 36259154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective cohort study on the correlation between high value of lactic acid and risk of death in 127 patients with extensive burn during shock stage].
    Ding XB; Chen J; Yang YT; Peng X; Yan H; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2019 May; 35(5):326-332. PubMed ID: 31154729
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
    Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of biochemical profile at admission with severity and outcome of COVID-19.
    Sadiq A; Khurram M; Malik J; Chaudhary NA; Khan MM; Yasmeen T; Bhatti HW
    J Community Hosp Intern Med Perspect; 2021; 11(6):740-746. PubMed ID: 34804383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the optimal cut-off values for liver enzymes in diagnosing blunt liver injury.
    Koyama T; Hamada H; Nishida M; Naess PA; Gaarder C; Sakamoto T
    BMC Res Notes; 2016 Jan; 9():41. PubMed ID: 26809874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of risk factors for prognosis of patients with acute paraquat intoxication].
    Fengjun J; Wen Z; Taoning W; Yaying Y; Kai K; Liu M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):906-10. PubMed ID: 27132458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Significant Prognostic But Not Predictive Biomarker in Japanese Patients with Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel.
    Miyake H; Matsushita Y; Watanabe H; Tamura K; Suzuki T; Motoyama D; Ito T; Sugiyama T; Otsuka A
    Anticancer Res; 2018 Jul; 38(7):4179-4185. PubMed ID: 29970547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction.
    Steininger M; Winter MP; Reiberger T; Koller L; El-Hamid F; Forster S; Schnaubelt S; Hengstenberg C; Distelmaier K; Goliasch G; Wojta J; Toma A; Niessner A; Sulzgruber P
    J Clin Med; 2018 Nov; 7(12):. PubMed ID: 30477196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
    Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
    Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
    Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
    Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.